- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00115921
Evaluation of Home-Based Management of Fever in Urban Ugandan Children
Studieoversigt
Status
Intervention / Behandling
Detaljeret beskrivelse
Population: Representative sample of Ugandan children aged 1 to 5 years from 400 households (approximately 540 children).
Clinical Site: The study will be conducted in the Mulago III parish community of Kampala, Uganda.
Study Duration: 13 months
Study Intervention: *Pilot period: After enrollment, households will participate in a one month pilot period to test the household pictorial diaries. At the end of the pilot period, households will be randomized to participation in the home-based management of fever (HBMF) arm or standard care arm for the remainder of the study (12 months). *HBMF arm: Households randomized to the HBMF group will be provided with pre-packaged coartemether to keep at home. Primary caregivers will be instructed to treat children participating in the study empirically with coartemether at home when the child develops fever. Study personnel will distribute drugs and educate the caregivers about administration of drugs, recognition of danger signs of fever/malaria, and when to seek additional care. *Standard care: Households randomized to the standard care arm will be asked to continue their current behaviour and to manage fever in their children as they would normally.
Measurements: Household diaries and monthly visits. Primary caregivers will be asked to keep a diary regarding the health of study participants for the duration of the study (13 months). Information on illnesses, treatments given, visits to health care facilities, and health care expenditures will be collected. Study personnel will visit the households monthly to collect completed diaries. At each visit, questionnaires will be administered to gather additional data on the health of the participants and treatment seeking behaviour.
Clinical and laboratory evaluations: Temperature, height, weight, mid-upper arm circumference, spleen size, haemoglobin, and thick blood smear will be assessed at enrollment, and at the beginning and end of the intervention period.
Study Objectives: 1. To measure the impact of home-based management of fever with coartemether on malaria-related morbidity compared to the current standard of care in the community.
2. To measure the impact of home-based management of fever with coartemether on economic measures compared to the current standard of care in the community.
Primary outcome: Treatment incidence density (treatments per time at risk) for each treatment arm
Secondary clinical outcomes: 1) mean days of fever; 2) incidence of febrile episodes; 3) mean haemoglobin at study end; 4) change in mean haemoglobin; 5) prevalence of splenomegaly; 6) prevalence of parasitaemia; 7) incidence of visits to health care facilities, and hospitalizations; 8) mortality rate; 9) anthropometric measurements; 10) proportion of "appropriate" treatments; 11) proportion of delayed treatments; 12) treatment incidence density of treatments given at >50% and at full dose
Economic outcomes: 1) household cost/febrile episode; 2) household costs for treatment of febrile episode/month; 3) provider cost/child for delivery of HBMF; 4) estimated provider facility cost/patient for uncomplicated fever, and for severe disease; 5) total net cost/child/year; 6) net cost/additional child appropriately treated; 7) net cost/day of fever averted
Undersøgelsestype
Tilmelding
Fase
- Ikke anvendelig
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Age 1 - 5 years
- Agreement of parents or guardians to provide informed consent
- Live in Mulago III Parish
Exclusion Criteria:
- History of any known serious chronic disease requiring frequent medical care (e.g. AIDS, sickle cell disease, malignancy)
- Intention to move from Kampala during the 13 month follow-up period
- History of serious side effects to study medications
- Weight < 10 kg
- Severe malnutrition defined as a weight-for-height or height-for-age Z-score < - 3
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
---|
The primary outcome measurement will be treatment incidence density (antimalarial treatments received per time at risk) for each study arm.
|
Sekundære resultatmål
Resultatmål |
---|
Dødeligheden
|
Mean days of fever per participant
|
Incidence of febrile episodes
|
Mean haemoglobin at study end
|
Change in mean haemoglobin between the start and end of the intervention
|
Incidence of visits to health care facilities (drug shops, clinics, pharmacies, hospitals) and hospitalizations per participant
|
Economic outcomes
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Sarah G Staedke, MD, University of California, San Francisco
- Ledende efterforsker: Christopher JM Whitty, FRCP, London School of Hygiene and Tropical Medicine
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- ITCRVG40
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Provision of antimalarial treatment at home
-
Memorial Sloan Kettering Cancer CenterAfsluttetFamilierne eller pårørende til patienter behandlet på MSKCC for ikke-kutane pladecellekarcinomer i | Øvre aerofordøjelseskanalForenede Stater
-
Copenhagen University Hospital at HerlevAfsluttetPostoperative komplikationer | Erektil dysfunktion | Intraoperative komplikationerDanmark
-
Memorial Sloan Kettering Cancer CenterAfsluttetAscitesForenede Stater
-
Zhujiang HospitalRekrutteringGliom af høj kvalitet | Strålingstoksicitet | Samlet overlevelse | Progressionsfri overlevelse | MR-simuleret positioneringKina
-
University of ReginaCanadian Institutes of Health Research (CIHR); Saskatchewan Health Authority... og andre samarbejdspartnereAktiv, ikke rekrutterendeGeneraliseret angstlidelse | Traumer og stressor-relaterede lidelser | Trauma | Større depressiv lidelse | Post traumatisk stress syndrom | Paniklidelse | Traumatisk stresslidelse | Stedfortrædende TraumeCanada
-
University of ReginaGovernment of Canada; Royal Canadian Mounted Police; Ministry of Public Safety... og andre samarbejdspartnereRekrutteringGeneraliseret angstlidelse | Trauma | Større depressiv lidelse | Post traumatisk stress syndrom | Paniklidelse | Traumatisk stresslidelse | Traumer og stressrelaterede lidelser | Stedfortrædende TraumeCanada
-
Boston University Charles River CampusNational Institute of Mental Health (NIMH); Kaiser Permanente; Silver Cloud...RekrutteringDepressive symptomer | Angstlidelser og symptomerForenede Stater
-
Duke UniversityAfsluttetMisofoniForenede Stater
-
Universidad Complutense de MadridUniversity of Alcala; Ministerio de Economía y Competitividad, Spain; Council...AfsluttetDepression | AngstSpanien
-
Hacettepe UniversityAnkara City Hospital BilkentAfsluttetKolorektal cancerKalkun